JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$1.18B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.07B |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$963M |
| 5 |
Medtronic
MDT
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.5B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$716M |
| 4 |
Chubb
CB
|
+$675M |
| 5 |
Lowe's Companies
LOW
|
+$661M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.13% |
| 2 | Financials | 15.03% |
| 3 | Technology | 12.86% |
| 4 | Healthcare | 9.44% |
| 5 | Consumer Discretionary | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FIT
2476
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $4.86M | ﹤0.01% |
953,323
-72,692
| -7% | -$387K |
2015 Q2
11 quarters
|
|
|
MRSN
2477
DELISTED
Mersana Therapeutics
MRSN
| $4.86M | ﹤0.01% |
12,327
-1,020
| -8% | -$403K |
2017 Q2
3 quarters
|
|
|
SHLM
2478
DELISTED
Schulman (A.) Inc
SHLM
| $4.86M | ﹤0.01% |
112,969
-85,398
| -43% | -$3.48M |
2013 Q2
19 quarters
|
|
2479
CALL
HCA Healthcare
HCA
$92.9B
| $4.85M | ﹤0.01% |
50,000
-59,900
| -55% | -$5.81M |
2017 Q2
3 quarters
|
|
|
2480
PUT
HCA Healthcare
HCA
$92.9B
| $4.85M | ﹤0.01% |
50,000
-133,900
| -73% | -$13M |
2017 Q2
3 quarters
|
|
2481
Iridium Communications
IRDM
$5.22B
| $4.84M | ﹤0.01% |
430,209
+211,675
| +97% | +$2.53M |
2014 Q4
13 quarters
|
|
|
BPMC
2482
DELISTED
Blueprint Medicines
BPMC
| $4.84M | ﹤0.01% |
52,758
+31,843
| +152% | +$2.74M |
2015 Q2
11 quarters
|
|
2483
HNI Corp
HNI
$3.4B
| $4.83M | ﹤0.01% |
133,733
+42,339
| +46% | +$1.62M |
2013 Q2
19 quarters
|
|
2484
Hyster-Yale Materials Handling
HY
$554M
| $4.82M | ﹤0.01% |
68,988
-4,395
| -6% | -$348K |
2013 Q2
19 quarters
|
|
2485
iShares Silver Trust
SLV
$29.2B
| $4.82M | ﹤0.01% |
312,913
-70,749
| -18% | -$1.12M |
2013 Q2
19 quarters
|
|
|
HA
2486
DELISTED
Hawaiian Holdings, Inc.
HA
| $4.82M | ﹤0.01% |
124,512
-332,699
| -73% | -$12.4M |
2013 Q2
19 quarters
|
|
|
RRD
2487
DELISTED
RR Donnelley & Sons Co.
RRD
| $4.82M | ﹤0.01% |
551,990
+331,196
| +150% | +$2.74M |
2016 Q4
5 quarters
|
|
2488
PUT
Costco
COST
$407B
| $4.8M | ﹤0.01% |
25,500
| – | – |
2017 Q1
4 quarters
|
|
|
BNY
2489
PUT
Bank of New York Mellon
BNY
$98.2B
| $4.8M | ﹤0.01% |
93,100
| – | – |
2017 Q3
2 quarters
|
|
|
POLY
2490
DELISTED
Plantronics, Inc.
POLY
| $4.8M | ﹤0.01% |
79,459
-105,568
| -57% | -$5.89M |
2014 Q4
13 quarters
|
|
|
FSCT
2491
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $4.78M | ﹤0.01% |
147,465
+106,989
| +264% | +$3.35M |
2017 Q4
1 quarter
|
|
2492
CALL
Bath & Body Works
BBWI
$3.26B
| $4.78M | ﹤0.01% |
154,625
+23,874
| +18% | +$903K |
2017 Q1
4 quarters
|
|
2493
ArcelorMittal
MT
$48.5B
| $4.78M | ﹤0.01% |
150,101
-5,264
| -3% | -$180K |
2013 Q2
19 quarters
|
|
2494
Vishay Precision Group
VPG
$1.05B
| $4.76M | ﹤0.01% |
152,844
-12,147
| -7% | -$346K |
2015 Q4
9 quarters
|
|
2495
Rollins
ROL
$14.7B
| $4.76M | ﹤0.01% |
209,801
-594,903
| -74% | -$13.1M |
2015 Q4
9 quarters
|
|
2496
Invesco S&P 500 Low Volatility ETF
SPLV
$7.03B
| $4.76M | ﹤0.01% |
101,303
-97,592
| -49% | -$4.62M |
2013 Q2
19 quarters
|
|
2497
Dine Brands
DIN
$375M
| $4.74M | ﹤0.01% |
72,332
-3,964
| -5% | -$242K |
2013 Q2
19 quarters
|
|
2498
PUT
Crown Castle
CCI
$28.1B
| $4.74M | ﹤0.01% |
43,200
-103,500
| -71% | -$11.2M |
2016 Q4
5 quarters
|
|
|
FMI
2499
PUT
DELISTED
Foundation Medicine, Inc.
FMI
| $4.72M | ﹤0.01% |
+60,000
| New | +$4.43M |
2018 Q1
0 quarters
|
|
2500
CALL
American Express
AXP
$204B
| $4.72M | ﹤0.01% |
50,600
+30,200
| +148% | +$2.93M |
2016 Q3
6 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2018 Portfolio in Review
As of Q1 2018, JP Morgan Chase held 5,855 positions worth $467B, down 1.7% from $475B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2018 filing shows 386 new, 1,953 increased, 2,569 reduced and 469 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M. The largest sale was Apple, an estimated $1.5B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, up from 22% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M.
- JP Morgan Chase added most to iShares MSCI Japan ETF in Q1 2018, an estimated $1.18B increase.
- JP Morgan Chase's biggest Q1 2018 reduction was Apple, cutting an estimated $1.5B.
- JP Morgan Chase fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $168M.
- JP Morgan Chase's ten largest holdings make up 18% of its $467B portfolio in Q1 2018.
- JP Morgan Chase opened 386 new positions and closed 469 in Q1 2018.
- JP Morgan Chase's portfolio value fell 1.7% quarter-over-quarter to $467B.
Based on JP Morgan Chase's 13F filing for Q1 2018, filed 10 May 2018.